Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.

Source:http://linkedlifedata.com/resource/pubmed/id/18205293

J. Med. Chem. 2008 Feb 14 51 3 449-69

Download in:

View as

General Info

PMID
18205293